发明名称 Expression profiling in non-small cell lung cancer
摘要 The present invention relates to L genes and gene products that are differentially expressed in cancer tissues and cell lines. In a particular aspect of the invention, L genes and gene products are differentially expressed in lung cancer tissues and cell lines. In accordance with the present invention, L nucleic acid sequences, amino acid sequences and antibodies thereto, and methods of use thereof are presented. The L molecules and methods of the invention may be used to monitor expression levels of L genes, wherein the detection of aberrant levels of L molecules provides a positive diagnostic indicator of lung cancer and/or other L gene associated cancers and a useful prognostic indice of the state of such diseases. Also provided are compounds capable of modulating an L molecule mediated activity, which are identified using the L molecules and methods of the invention. Such L molecule modulating compounds may be used efficaciously to treat patients with lung cancer, or other L antigen positive cancers.
申请公布号 US2005272061(A1) 申请公布日期 2005.12.08
申请号 US20050063343 申请日期 2005.02.22
申请人 SEATTLE GENETICS, INC. 发明人 PETROZIELLO JOSEPH M.;CARTER PAUL
分类号 C12Q1/68;G01N33/574;(IPC1-7):C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址